fludarabine phosphate, cyclophosphamide, and rituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for fludarabine phosphate, cyclophosphamide, and rituximab, covering 2023-08-14 to 2023-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]